OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
May 15, 2020
Ensuring the quality of data in process monitoring and control systems starts in process development phases.
May 02, 2020
Many antibody-drug conjugate therapies are in the pipeline; however, only a handful have been approved. What are the bottlenecks?
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
April 02, 2020
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
March 02, 2020
Formulating fixed-dose combination drugs proves more complex than simply adding one ingredient to another.
February 02, 2020
Researching excipient grades and sources, as well as screening suppliers and materials, form the basis of programs to mitigate risk.